Authors: Shum, PW Peet, NP Weintraub, PM Le, TB Zhao, Z Barbone, F Cashman, B Tsay, J Dwyer, S Loos, PC Powers, EA Kropp, K Wright, PS Bitonti, A Dumont, J Borcherding, DR

Citation: Pw. Shum et al., The design and synthesis of purine inhibitors of CDK2. III, NUCLEOS NUC, 20(4-7), 2001, pp. 1067-1078

Authors: Woessner, R An, ZL Li, XM Hoffman, RM Dix, R Bitonti, A

Citation: R. Woessner et al., Comparison of three approaches to doxorubicin therapy: Free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826), ANTICANC R, 20(4), 2000, pp. 2289-2296